Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer von Saltz, Leonard B, Cox, John V, Blanke, Charles, Rosen, Lee S, Fehrenbacher, Louis, Moore, Malcolm J, Maroun, Jean A, Ackland, Stephen P, Locker, Paula K, Pirotta, Nicoletta, Elfring, Gary L, Miller, Langdon L

Volltext

Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans von Hughes, Jr, Antal, Edward J, Locker, Paula K, Francom, Steven F, Adams, Wade J, Jacobs, Jr

Volltext

Irinotecan Plus Gemcitabine Induces Both Radiographic and CA 19-9 Tumor Marker Responses in Patients With Previously Untreated Advanced Pancreatic Cancer von Rocha Lima, C. M. S.

Volltext

Phase I Trial of the Combination of Irinotecan, Paclitaxel, and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer von SOCINSKI, Mark A, SANDLER, Alan B, MILLER, Langdon L, LOCKER, Paula K, HANOVER, Cristy K, ELFRING, Gary L, ISRAEL, Valerie K, PIROTTA, Nicoletta, NATALE, Ronald B

Volltext

Irinotecan Plus Fluorouracil/Leucovorin for Metastatic Colorectal Cancer: A New Survival Standard von Saltz, Leonard B., Douillard, Jean‐Yves, Pirotta, Nicoletta, Alakl, May, Gruia, Gabriela, Awad, Lucile, Elfring, Gary L., Locker, Paula K., Miller, Langdon L.

Volltext

Phase I and Pharmacokinetic Trial of Oral Irinotecan Administered Daily for 5 Days Every 3 Weeks in Patients With Solid Tumors von DRENGLER, R. L, KUHN, J. G, ELFRING, G. L, LOCKER, P. K, MILLER, L. L, VON HOFF, D. D, ROTHENBERG, M. L, SCHAAF, L. J, RODRIGUEZ, G. I, VILLALONA-CALERO, M. A, HAMMOND, L. A, STEPHENSON, J. A, HODGES, S, KRAYNAK, M. A, STATON, B. A

Volltext

Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma von Socinski, Mark A., Sandler, Alan B., Israel, Valerie K., Gillenwater, Heidi H., Miller, Langdon L., Locker, Paula K., Antonellini, Alessandro, Elfring, Gary L., Natale, Ronald B.

Volltext

Irinotecan plus gemcitabine induces both radiographic and CA 19-9 tumor marker responses in patients with previously untreated advanced pancreatic cancer von ROCHA LIMA, Caio Max S, SAVARESE, Diane, ELFRING, Gary L, LOCKER, Paula K, COMPTON, Linda D, MILLER, Langdon L, GREEN, Mark R, BRUCKNER, Howard, DUDEK, Arkadiusz, ECKARDT, John, HAINSWORTH, John, YUNUS, Furhan, LESTER, Eric, MILLER, William, SAVILLE, Wayne

Volltext

N-[(.omega.-Amino-1-hydroxyalkyl)phenyl]methanesulfonamide derivatives with class III antiarrhythmic activity von Hester, Jackson B, Gibson, J. Kenneth, Cimini, Madeline G, Emmert, D. Edward, Locker, Paula K, Perricone, Salvatore C, Skaletzky, Louis L, Sykes, Julie K, West, Bruce E

Volltext

Effects of a Novel Hemoglobin-Based Oxygen Carrier on Percent Oxygen Saturation as Determined With Arterial Blood Gas Analysis and Pulse Oximetry von Hughes, George S, Francom, Steven F, Antal, Edward J, Adams, Wade J, Locker, Paula K, Yancey, Elizabeth P, Jacobs, Edward E

Volltext

Irinotecan (CPT-11) in triplet combinations in patients with advanced non small-cell lung cancer: a review and report of a phase I/II trial von Socinski, M A, Sandler, A B, Miller, L L, Locker, P K, Hanover, C K, Elfring, G L, Israel, V K, Pirotta, N, Natale, R B

Volltext

Improved Sleep, Memory, and Cellular Pathological Features of Tauopathy, Including the NLRP3 Inflammasome, after Chronic Administration of Trazodone in rTg4510 Mice von de Oliveira, Paula, Cella, Claire, Locker, Nicolas, Ravindran, Kiran K G, Mendis, Agampodi, Wafford, Keith, Gilmour, Gary, Dijk, Derk-Jan, Winsky-Sommerer, Raphaelle

Volltext